Lv11
80 积分 2024-12-08 加入
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation
10天前
已完结
Safety and efficacy of moderate‐intensity statin with ezetimibe in elderly patients with atherosclerotic cardiovascular disease
27天前
已完结
Severe cutaneous adverse reactions associated with antifungal agents: a pharmacovigilance analysis based on the FDA adverse event reporting System（faers）database
29天前
已完结
Colchicine in acute coronary syndromes: the present and the possible future
1个月前
已完结
Pro-arrhythmic potential of proton-pump inhibitors
1个月前
已完结
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
1个月前
已完结
Comparative effectiveness of sacubitril/valsartan versus angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction
1个月前
已完结
Eosinophil-induced adverse events induced by treatment with programmed cell death 1/ligand 1 inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system
1个月前
已完结
Drug-Induced Hypouricemia
1个月前
已完结
皖公网安备34019202002308
